The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biological Defense Market Research Report 2025
Synopsis
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
The global Biological Defense market was valued at US$ 1144 million in 2023 and is anticipated to reach US$ 1452.8 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market. North America, Europe and Asia are key Regions of Sales. Anthrax and Smallpox are main types, with a share about 70%. US Civilian Market is the main application, which holds a share about 55%.
This report aims to provide a comprehensive presentation of the global market for Biological Defense, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Defense.
Report Scope
The Biological Defense market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biological Defense market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Defense companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
SIGA Technologies
Ichor Medical Systems
Emergent BioSolutions
Elusys Therapeutics
DynPort Vaccine Company
Altimmune
Cleveland BioLabs
Bavarian Nordic
Alnylam Pharmaceuticals
Achaogen
Alexeter Technologies
ANP Technologies
PathSensors
New Horizons Diagnostics
BBI Detection
Segment by Type
Anthrax
Small Pox
Botox
Radiation / Nuclear
Other
Segment by Application
Military
Civilian
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biological Defense companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
The global Biological Defense market was valued at US$ 1144 million in 2023 and is anticipated to reach US$ 1452.8 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market. North America, Europe and Asia are key Regions of Sales. Anthrax and Smallpox are main types, with a share about 70%. US Civilian Market is the main application, which holds a share about 55%.
This report aims to provide a comprehensive presentation of the global market for Biological Defense, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Defense.
Report Scope
The Biological Defense market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biological Defense market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Defense companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
SIGA Technologies
Ichor Medical Systems
Emergent BioSolutions
Elusys Therapeutics
DynPort Vaccine Company
Altimmune
Cleveland BioLabs
Bavarian Nordic
Alnylam Pharmaceuticals
Achaogen
Alexeter Technologies
ANP Technologies
PathSensors
New Horizons Diagnostics
BBI Detection
Segment by Type
Anthrax
Small Pox
Botox
Radiation / Nuclear
Other
Segment by Application
Military
Civilian
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biological Defense companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biological Defense Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anthrax
1.2.3 Small Pox
1.2.4 Botox
1.2.5 Radiation / Nuclear
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biological Defense Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Military
1.3.3 Civilian
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biological Defense Market Perspective (2019-2030)
2.2 Biological Defense Growth Trends by Region
2.2.1 Global Biological Defense Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biological Defense Historic Market Size by Region (2019-2024)
2.2.3 Biological Defense Forecasted Market Size by Region (2025-2030)
2.3 Biological Defense Market Dynamics
2.3.1 Biological Defense Industry Trends
2.3.2 Biological Defense Market Drivers
2.3.3 Biological Defense Market Challenges
2.3.4 Biological Defense Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biological Defense Players by Revenue
3.1.1 Global Top Biological Defense Players by Revenue (2019-2024)
3.1.2 Global Biological Defense Revenue Market Share by Players (2019-2024)
3.2 Global Biological Defense Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biological Defense Revenue
3.4 Global Biological Defense Market Concentration Ratio
3.4.1 Global Biological Defense Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biological Defense Revenue in 2023
3.5 Biological Defense Key Players Head office and Area Served
3.6 Key Players Biological Defense Product Solution and Service
3.7 Date of Enter into Biological Defense Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biological Defense Breakdown Data by Type
4.1 Global Biological Defense Historic Market Size by Type (2019-2024)
4.2 Global Biological Defense Forecasted Market Size by Type (2025-2030)
5 Biological Defense Breakdown Data by Application
5.1 Global Biological Defense Historic Market Size by Application (2019-2024)
5.2 Global Biological Defense Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biological Defense Market Size (2019-2030)
6.2 North America Biological Defense Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biological Defense Market Size by Country (2019-2024)
6.4 North America Biological Defense Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biological Defense Market Size (2019-2030)
7.2 Europe Biological Defense Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biological Defense Market Size by Country (2019-2024)
7.4 Europe Biological Defense Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biological Defense Market Size (2019-2030)
8.2 Asia-Pacific Biological Defense Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biological Defense Market Size by Region (2019-2024)
8.4 Asia-Pacific Biological Defense Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biological Defense Market Size (2019-2030)
9.2 Latin America Biological Defense Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biological Defense Market Size by Country (2019-2024)
9.4 Latin America Biological Defense Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biological Defense Market Size (2019-2030)
10.2 Middle East & Africa Biological Defense Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biological Defense Market Size by Country (2019-2024)
10.4 Middle East & Africa Biological Defense Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SIGA Technologies
11.1.1 SIGA Technologies Company Detail
11.1.2 SIGA Technologies Business Overview
11.1.3 SIGA Technologies Biological Defense Introduction
11.1.4 SIGA Technologies Revenue in Biological Defense Business (2019-2024)
11.1.5 SIGA Technologies Recent Development
11.2 Ichor Medical Systems
11.2.1 Ichor Medical Systems Company Detail
11.2.2 Ichor Medical Systems Business Overview
11.2.3 Ichor Medical Systems Biological Defense Introduction
11.2.4 Ichor Medical Systems Revenue in Biological Defense Business (2019-2024)
11.2.5 Ichor Medical Systems Recent Development
11.3 Emergent BioSolutions
11.3.1 Emergent BioSolutions Company Detail
11.3.2 Emergent BioSolutions Business Overview
11.3.3 Emergent BioSolutions Biological Defense Introduction
11.3.4 Emergent BioSolutions Revenue in Biological Defense Business (2019-2024)
11.3.5 Emergent BioSolutions Recent Development
11.4 Elusys Therapeutics
11.4.1 Elusys Therapeutics Company Detail
11.4.2 Elusys Therapeutics Business Overview
11.4.3 Elusys Therapeutics Biological Defense Introduction
11.4.4 Elusys Therapeutics Revenue in Biological Defense Business (2019-2024)
11.4.5 Elusys Therapeutics Recent Development
11.5 DynPort Vaccine Company
11.5.1 DynPort Vaccine Company Company Detail
11.5.2 DynPort Vaccine Company Business Overview
11.5.3 DynPort Vaccine Company Biological Defense Introduction
11.5.4 DynPort Vaccine Company Revenue in Biological Defense Business (2019-2024)
11.5.5 DynPort Vaccine Company Recent Development
11.6 Altimmune
11.6.1 Altimmune Company Detail
11.6.2 Altimmune Business Overview
11.6.3 Altimmune Biological Defense Introduction
11.6.4 Altimmune Revenue in Biological Defense Business (2019-2024)
11.6.5 Altimmune Recent Development
11.7 Cleveland BioLabs
11.7.1 Cleveland BioLabs Company Detail
11.7.2 Cleveland BioLabs Business Overview
11.7.3 Cleveland BioLabs Biological Defense Introduction
11.7.4 Cleveland BioLabs Revenue in Biological Defense Business (2019-2024)
11.7.5 Cleveland BioLabs Recent Development
11.8 Bavarian Nordic
11.8.1 Bavarian Nordic Company Detail
11.8.2 Bavarian Nordic Business Overview
11.8.3 Bavarian Nordic Biological Defense Introduction
11.8.4 Bavarian Nordic Revenue in Biological Defense Business (2019-2024)
11.8.5 Bavarian Nordic Recent Development
11.9 Alnylam Pharmaceuticals
11.9.1 Alnylam Pharmaceuticals Company Detail
11.9.2 Alnylam Pharmaceuticals Business Overview
11.9.3 Alnylam Pharmaceuticals Biological Defense Introduction
11.9.4 Alnylam Pharmaceuticals Revenue in Biological Defense Business (2019-2024)
11.9.5 Alnylam Pharmaceuticals Recent Development
11.10 Achaogen
11.10.1 Achaogen Company Detail
11.10.2 Achaogen Business Overview
11.10.3 Achaogen Biological Defense Introduction
11.10.4 Achaogen Revenue in Biological Defense Business (2019-2024)
11.10.5 Achaogen Recent Development
11.11 Alexeter Technologies
11.11.1 Alexeter Technologies Company Detail
11.11.2 Alexeter Technologies Business Overview
11.11.3 Alexeter Technologies Biological Defense Introduction
11.11.4 Alexeter Technologies Revenue in Biological Defense Business (2019-2024)
11.11.5 Alexeter Technologies Recent Development
11.12 ANP Technologies
11.12.1 ANP Technologies Company Detail
11.12.2 ANP Technologies Business Overview
11.12.3 ANP Technologies Biological Defense Introduction
11.12.4 ANP Technologies Revenue in Biological Defense Business (2019-2024)
11.12.5 ANP Technologies Recent Development
11.13 PathSensors
11.13.1 PathSensors Company Detail
11.13.2 PathSensors Business Overview
11.13.3 PathSensors Biological Defense Introduction
11.13.4 PathSensors Revenue in Biological Defense Business (2019-2024)
11.13.5 PathSensors Recent Development
11.14 New Horizons Diagnostics
11.14.1 New Horizons Diagnostics Company Detail
11.14.2 New Horizons Diagnostics Business Overview
11.14.3 New Horizons Diagnostics Biological Defense Introduction
11.14.4 New Horizons Diagnostics Revenue in Biological Defense Business (2019-2024)
11.14.5 New Horizons Diagnostics Recent Development
11.15 BBI Detection
11.15.1 BBI Detection Company Detail
11.15.2 BBI Detection Business Overview
11.15.3 BBI Detection Biological Defense Introduction
11.15.4 BBI Detection Revenue in Biological Defense Business (2019-2024)
11.15.5 BBI Detection Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Biological Defense Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Anthrax
Table 3. Key Players of Small Pox
Table 4. Key Players of Botox
Table 5. Key Players of Radiation / Nuclear
Table 6. Key Players of Other
Table 7. Global Biological Defense Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Biological Defense Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Biological Defense Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Biological Defense Market Share by Region (2019-2024)
Table 11. Global Biological Defense Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Biological Defense Market Share by Region (2025-2030)
Table 13. Biological Defense Market Trends
Table 14. Biological Defense Market Drivers
Table 15. Biological Defense Market Challenges
Table 16. Biological Defense Market Restraints
Table 17. Global Biological Defense Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Biological Defense Market Share by Players (2019-2024)
Table 19. Global Top Biological Defense Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Defense as of 2023)
Table 20. Ranking of Global Top Biological Defense Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Biological Defense Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Biological Defense Product Solution and Service
Table 24. Date of Enter into Biological Defense Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biological Defense Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Biological Defense Revenue Market Share by Type (2019-2024)
Table 28. Global Biological Defense Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Biological Defense Revenue Market Share by Type (2025-2030)
Table 30. Global Biological Defense Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Biological Defense Revenue Market Share by Application (2019-2024)
Table 32. Global Biological Defense Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Biological Defense Revenue Market Share by Application (2025-2030)
Table 34. North America Biological Defense Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Biological Defense Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Biological Defense Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Biological Defense Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Biological Defense Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Biological Defense Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Biological Defense Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Biological Defense Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Biological Defense Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Biological Defense Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Biological Defense Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Biological Defense Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Biological Defense Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Biological Defense Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Biological Defense Market Size by Country (2025-2030) & (US$ Million)
Table 49. SIGA Technologies Company Detail
Table 50. SIGA Technologies Business Overview
Table 51. SIGA Technologies Biological Defense Product
Table 52. SIGA Technologies Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 53. SIGA Technologies Recent Development
Table 54. Ichor Medical Systems Company Detail
Table 55. Ichor Medical Systems Business Overview
Table 56. Ichor Medical Systems Biological Defense Product
Table 57. Ichor Medical Systems Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 58. Ichor Medical Systems Recent Development
Table 59. Emergent BioSolutions Company Detail
Table 60. Emergent BioSolutions Business Overview
Table 61. Emergent BioSolutions Biological Defense Product
Table 62. Emergent BioSolutions Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 63. Emergent BioSolutions Recent Development
Table 64. Elusys Therapeutics Company Detail
Table 65. Elusys Therapeutics Business Overview
Table 66. Elusys Therapeutics Biological Defense Product
Table 67. Elusys Therapeutics Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 68. Elusys Therapeutics Recent Development
Table 69. DynPort Vaccine Company Company Detail
Table 70. DynPort Vaccine Company Business Overview
Table 71. DynPort Vaccine Company Biological Defense Product
Table 72. DynPort Vaccine Company Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 73. DynPort Vaccine Company Recent Development
Table 74. Altimmune Company Detail
Table 75. Altimmune Business Overview
Table 76. Altimmune Biological Defense Product
Table 77. Altimmune Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 78. Altimmune Recent Development
Table 79. Cleveland BioLabs Company Detail
Table 80. Cleveland BioLabs Business Overview
Table 81. Cleveland BioLabs Biological Defense Product
Table 82. Cleveland BioLabs Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 83. Cleveland BioLabs Recent Development
Table 84. Bavarian Nordic Company Detail
Table 85. Bavarian Nordic Business Overview
Table 86. Bavarian Nordic Biological Defense Product
Table 87. Bavarian Nordic Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 88. Bavarian Nordic Recent Development
Table 89. Alnylam Pharmaceuticals Company Detail
Table 90. Alnylam Pharmaceuticals Business Overview
Table 91. Alnylam Pharmaceuticals Biological Defense Product
Table 92. Alnylam Pharmaceuticals Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 93. Alnylam Pharmaceuticals Recent Development
Table 94. Achaogen Company Detail
Table 95. Achaogen Business Overview
Table 96. Achaogen Biological Defense Product
Table 97. Achaogen Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 98. Achaogen Recent Development
Table 99. Alexeter Technologies Company Detail
Table 100. Alexeter Technologies Business Overview
Table 101. Alexeter Technologies Biological Defense Product
Table 102. Alexeter Technologies Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 103. Alexeter Technologies Recent Development
Table 104. ANP Technologies Company Detail
Table 105. ANP Technologies Business Overview
Table 106. ANP Technologies Biological Defense Product
Table 107. ANP Technologies Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 108. ANP Technologies Recent Development
Table 109. PathSensors Company Detail
Table 110. PathSensors Business Overview
Table 111. PathSensors Biological Defense Product
Table 112. PathSensors Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 113. PathSensors Recent Development
Table 114. New Horizons Diagnostics Company Detail
Table 115. New Horizons Diagnostics Business Overview
Table 116. New Horizons Diagnostics Biological Defense Product
Table 117. New Horizons Diagnostics Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 118. New Horizons Diagnostics Recent Development
Table 119. BBI Detection Company Detail
Table 120. BBI Detection Business Overview
Table 121. BBI Detection Biological Defense Product
Table 122. BBI Detection Revenue in Biological Defense Business (2019-2024) & (US$ Million)
Table 123. BBI Detection Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biological Defense Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Biological Defense Market Share by Type: 2023 VS 2030
Figure 3. Anthrax Features
Figure 4. Small Pox Features
Figure 5. Botox Features
Figure 6. Radiation / Nuclear Features
Figure 7. Other Features
Figure 8. Global Biological Defense Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Biological Defense Market Share by Application: 2023 VS 2030
Figure 10. Military Case Studies
Figure 11. Civilian Case Studies
Figure 12. Other Case Studies
Figure 13. Biological Defense Report Years Considered
Figure 14. Global Biological Defense Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Biological Defense Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Biological Defense Market Share by Region: 2023 VS 2030
Figure 17. Global Biological Defense Market Share by Players in 2023
Figure 18. Global Top Biological Defense Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Defense as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Biological Defense Revenue in 2023
Figure 20. North America Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Biological Defense Market Share by Country (2019-2030)
Figure 22. United States Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Biological Defense Market Share by Country (2019-2030)
Figure 26. Germany Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Biological Defense Market Share by Region (2019-2030)
Figure 34. China Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Biological Defense Market Share by Country (2019-2030)
Figure 42. Mexico Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Biological Defense Market Share by Country (2019-2030)
Figure 46. Turkey Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Biological Defense Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. SIGA Technologies Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 49. Ichor Medical Systems Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 50. Emergent BioSolutions Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 51. Elusys Therapeutics Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 52. DynPort Vaccine Company Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 53. Altimmune Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 54. Cleveland BioLabs Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 55. Bavarian Nordic Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 56. Alnylam Pharmaceuticals Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 57. Achaogen Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 58. Alexeter Technologies Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 59. ANP Technologies Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 60. PathSensors Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 61. New Horizons Diagnostics Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 62. BBI Detection Revenue Growth Rate in Biological Defense Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
